Diagnosis and management of vitamin D deficiency by Pearce SHS & Cheetham TD
142   BMJ | 16 January 2010 | VoluMe 340
CliniCal Review For the full versions of these articles see bmj.com
Rickets in children and osteomalacia in adults are the 
classic manifestations of profound vitamin D deficiency. 
In recent years, however, non-musculoskeletal condi-
tions—including cancer, metabolic syndrome, infectious 
and autoimmune disorders—have also been found to be 
associated with low vitamin D levels.1 The spectrum of 
these common disorders is of particular concern because 
observational studies have demonstrated that vitamin 
D insufficiency is widespread in many northern regions 
of the world, including industrialised countries.2 3 The 
increasing prevalence of disorders linked to vitamin D 
deficiency is reflected in the several hundred children 
with rickets treated each year in the UK.4 However, 
these children represent a small proportion of the indi-
viduals with a suboptimal vitamin D status in the UK 
 population.1 3 5
A recent nationwide survey in the United Kingdom 
showed that more than 50% of the adult population 
have insufficient levels of vitamin D and that 16% have 
severe deficiency during winter and spring.5 The survey 
also demonstrated a gradient of prevalence across the 
UK, with highest rates in Scotland, northern England, 
and Northern Ireland.5 People with pigmented skin are at 
high risk, as are the elderly; obese individuals; those with 
malabsorption, short bowel, or renal or liver disease; and 
individuals t aking anticonvulsants, rifampicin, or highly 
active anti retroviral drugs.
In this article we discuss the diagnosis and manage-
ment of vitamin D insufficiency and deficiency in chil-
dren and adults according to evidence from descriptive 
and observational studies, randomised trials, and meta-
analyses.
what are the sources of vitamin D?
Vitamin D refers to the precursors of the active secosteroid 
hormone 1,25-dihydroxyvitamin D3 (1,25-OH2D3), also 
known as calcitriol. The major natural source of vitamin 
D is from skin photosynthesis following ultraviolet B solar 
irradiation (box 1). 
In a fair skinned person, 20 minutes to 30 minutes of 
sunlight exposure on the face and forearms at midday is 
estimated to generate the equivalent of around 2000 IU of 
vitamin D. Two or three such sunlight exposures a week are 
sufficient to achieve healthy vitamin D levels in summer 
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SummaRy PointS
Vitamin D insufficiency is common in the UK population
Vitamin D deficiency typically presents with bony deformity (rickets) or hypocalcaemia in 
infancy and childhood, and with musculoskeletal pain and weakness in adults
Many other health problems—including cardiovascular disease, type 2 diabetes, several 
cancers, and autoimmune conditions—have recently been associated with vitamin D 
insufficiency   
Risk factors include skin pigmentation, use of sunscreen or concealing clothing, being elderly or 
institutionalised, obesity, malabsorption, renal and liver disease, and anticonvulsant use
Vitamin D status is most reliably determined by assay of serum 25-hydroxyvitamin D (25-OHD)
Rickets and osteomalacia should be treated with high strength calciferol (ergocalciferol or 
colecalciferol) for 8-12 weeks, followed by regular vitamin D supplements
Box 1 | Sources of vitamin D
Ultraviolet B sunlight exposure •	
>90% of humankind’s vitamin D supply is derived from 
ultraviolet B light
Oily fish including trout, salmon, mackerel, herring, •	
sardines, anchovies, pilchards, and fresh tuna 
Amount will depend on preparation, with smoked herring 
containing approximately 4 μg (160 IU) per 100 g and raw 
herring 40 μg (1600 IU) per 100 g
Cod liver oil and other fish oils•	
Egg yolk •	
0.5 μg (20 IU) per yolk)
Mushrooms •	
Small quantities
Supplemented breakfast cereals, mainly supermarket •	
“own brands” in the UK 
Typically between 2 μg and 8 μg (80-320 IU) per 100 g
Margarine and infant formula milk •	
Statutory supplementation in the UK
table 1 | Serum 25-hydroxyvitamin D concentrations,  
health, and disease
Serum 25-OHD 
concentration* 
Vitamin D 
status Manifestation Management
<25 nmol/l Deficient Rickets
Osteomalacia
Treat with  
high-dose  
calciferol
25-50 nmol/l Associated with 
disease risk
Vitamin D 
supplementation
50-75 nmol/l Adequate Healthy Lifestyle advice
>75 nmol/l Optimal Healthy None
*To convert to μg/l divide by 2.5.
SourCeS anD 
SeleCtion Criteria
We searched the PubMed 
database for articles 
including the term 
vitamin D. We identified 
further references from 
the original articles and 
recent review articles. We 
only studied articles in 
the English language, and 
gave priority to systemic 
reviews, meta-analyses, 
and clinical guidelines 
published within the past 
10 years. 
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table 2 | Evidence for association of circulating 25-hydroxyvitamin D level or vitamin D supplementation with major health outcomes
Design Number of Comparator
Odds/hazard ratio 
or relative risk§ 
(95% CI)
All cause mortality
Autier and Gandini, 200710 Meta-analysis of 18 vitamin D supplementation studies 57 311 Supplemented v unsupplemented RR 0.93 (0.87 to 0.99)
Ginde et al, 200912 Prospective observational study in individuals >65 years* 3265 Serum 25-OHD concentration >100 nmol/l v <25 nmol/l
HR 0.55 (0.34 to 
0.88)
Dobnig et al, 200813 Prospective cohort study with coronary angiography† 3258 Median serum 25-OHD concentration 70 nmol/l v 19 nmol/l‡ HR 0.48 (0.37 to 0.630
Cardiovascular mortality
Ginde et al, 200912 Prospective observational study in individuals >65 years* 3265 Serum 25-OHD concentration >100 nmol/l v <25 nmol/l
HR 0.42 (0.21 to 
0.85)
Dobnig et al, 200813 Prospective cohort study with coronary angiography† 3258 Median serum 25-OHD concentration 70 nmol/l v 19 nmol/l‡ HR 0.45 (0.32 to 0.64)
Diabetes
Type 1
 Zipitis and Akobeng, 
200818
Meta-analysis of four case-control studies of vitamin D 
supplementation
6455 Supplemented v unsupplemented OR 0.71 (0.60 to 
0.84)
Type 2
 Pittas et al, 200714 Meta-analysis of four observational studies 6784  
(non-black)
Serum 25-OHD concentration 63-95 nmol/l v 25-58 nmol/l OR 0.36 (0.16 to 
0.80)
Cancer
Colorectal 
 Yin et al, 200915 Meta-analysis of six case-control studies 3556 Per 50 nmol/l increase in serum 25-OHD concentration OR 0.57 (0.43 to 
0.76)
Breast
in the UK. For individuals with pigmented skin and, to a 
lesser extent, the elderly, exposure time or frequency need 
to be increased twofold to 10-fold to get the same level of 
vitamin D synthesis as fair skinned young individuals.6 w1 
Unfortunately, for six months of the year (October to April), 
all of Scandinavia, much of western Europe (including 
90% of the UK), and 50% of the North American landmass 
lies above the latitude that permits exposure to the ultra-
violet B wavelengths necessary for vitamin D synthesis,w2 
leaving millions of people reliant on exogenous sources 
of vitamin D. 
Given this periodic lack of photosynthesis at high lati-
tudes, vitamin D is also a micronutrient. Only a relatively 
small number of foods contain substantial amounts of 
vitamin D, the most significant dietary sources being oily 
fish and cod liver oil.7 The farmed fish that is commonly 
consumed in the UK may have less vitamin D content than 
wild fish.w3 Egg yolk, liver, and wild mushrooms contain 
small quantities of vitamin D. The amount in most vegeta-
ble sources is negligible. 
The recommended daily intake of vitamin D in the UK 
is 400 IU (10 μg) per day for an adult, 280 IU (7 μg) for 
children aged between 6 months and 3 years, and 340 IU 
(8.5 μg) per day for infants under 6 months.7 However, 
these recommendations only provide sufficient vitamin D 
to prevent osteomalacia and rickets,8 and such an intake 
alone, in the absence of skin synthesis, will not provide 
optimal status. Accordingly, several learned bodies have 
recently increased their recommendations for vitamin D 
intake.9 w4 
Food supplementation policies differ considerably 
between countries. Milk is widely fortified, but in the UK 
only infant formula milk and margarine have statutory 
vitamin D supplementation (1-2.5 μg (40-100 IU) per 
100 kCal and 8 μg (320 IU) per 100 g, respectively). Thus, 
the typical UK diet, and that of many other countries, is 
profoundly lacking in vitamin D. A low dietary vitamin D 
intake, co mbined with the lack of skin synthesis for half 
of the year, is reflected in the disturbingly high prevalence 
of vitamin D insufficiency across the UK.3 5
how can vitamin D deficiency and insufficiency be 
determined?
Vitamin D status is most reliably determined by assay of 
serum 25-hydroxyvitamin D (25-OHD). Individuals with 
symptomatic osteomalacia or rickets have serum 25-OHD 
concentrations of less than 25 nmol/l (10 μg/l), reflect-
ing profound vitamin D deficiency (table 1). A much 
larger proportion of the UK population (about 50% in 
spring) have vitamin D insufficiency, with serum 25-
OHD c oncentrations between 25 nmol/l and 50 nmol/l 
(10-20 μg/l).3 5 
Several observational studies have shown that vitamin D 
insufficiency, although not enough to cause symptomatic 
bone and muscle disease, is associated with an increased 
risk of mortality10-13 and of several common diseases includ-
ing cardiovascular disease,12 13 type 2 diabetes,14 bowel 
cancer, breast cancer,15 16 multiple sclerosis,17 and type 
1 diabetes18 (table 2). An expert consensus is developing 
that optimal vitamin D status, reflected by optimal calcium 
handling and best health, is when serum concentrations of 
25-OHD are 75 nmol/l (30 μg/l) or more.8 19 Serum 25-OHD 
has a circulating half life of two to three weeks, but levels 
are regularly replenished from fat stores. 
Circulating active vitamin D (1,25-dihydroxyvitamin 
D3 or calcitriol) has a short half life and is closely linked 
to parathyroid hormone production. Serum levels of cal-
citriol do not reflect vitamin D status and should not be 
measured unless abnormalities of vitamin D metabolism 
are suspected.
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Box 2 | risk factors for vitamin D insufficiency and deficiency
Pigmented skin (non-white ethnicity)•	
Lack of sunlight exposure or atmospheric pollution•	
Skin concealing garments or strict sunscreen use•	
Exclusively breast fed •	
Multiple, short interval pregnancies•	
Elderly, obese, or institutionalised•	
Vegetarian (or other non-fish eating) diet•	
Malabsorption, short bowel, or cholestatic liver disease•	
Use of anticonvulsants, rifampicin, cholestyramine, highly active antiretroviral treatment •	
(HAART), or glucocorticoids
Box 3 | Preparations of calciferol available in the uK
Solutions and drops
Dalivit (LPC Pharmaceuticals Ltd, Luton, Bedfordshire)*•	
Colecalciferol 400 IU per 0.6 ml
Abidec (Chefaro UK, Huntingdon, Cambridgeshire)*•	
Colecalciferol 400 IU per 0.6 ml
Healthy Start vitamin drops*•	
Colecalciferol 300 IU per 5 drops
Ergocalciferol oily solution •	
3000 IU/ml
tablets and capsules†
Calcium and vitamin D (400 mg calcium and 400 IU ergocalciferol)•	
Colecalciferol 20 000 IU (Dekristol; MIBE, Brehna, Germany)•	
Ergocalciferol 10 000 IU or 50 000 IU (UCB Pharma, Slough, Berkshire)•	
Parenteral
Ergocalciferol 300 000 IU per ml•	
*Multivitamin preparations; not suitable for prolonged high dose therapy owing to the risk of vitamin A 
toxicity.
†Other ergocalciferol and colecalciferol preparations are available off prescription.
Box 4 | treatment of vitamin D deficiency and insufficiency
Deficiency (25-oHD <25 nmol/l)
adult
10 000 IU calciferol daily or 60 000 IU calciferol weekly for •	
8-12 weeks*
or
Calciferol 300 000 or 600 000 IU orally or by •	
intramuscular injection once or twice 
Child
Under 6 months: 3000 IU calciferol daily for 8-12 weeks•	
Over 6 months: 6000 IU calciferol daily for 8-12 weeks•	
or
Over 1 year: 300 000 IU calciferol, as a one off high dose •	
therapy (Stoss regimen)†
insufficiency (25-oHD 25-50 nmol/l) or maintenance 
therapy following deficiency
adult 
1000-2000 IU calciferol daily •	
or
10 000 IU calciferol weekly•	
Child
Under 6 months: 200-400 IU calciferol daily‡•	
Over 6 months: 400-800 IU calciferol daily•	
*To convert IU to μg of calciferol, divide by 40.
†One off high dose treatments are effective, but should be followed 
by a maintenance therapy dose of calciferol.
‡200 IU may be inadequate for breastfed babies with low vitamin D 
stores at birth.
who is at risk of vitamin D insufficiency and deficiency?
At northern latitudes, the major risk factor for D insuffi-
ciency and deficiency at all ages is pigmented skin (box 
2). This is also a key risk factor in sunnier climates such 
as Australia, where a large case series has demonstrated 
an increasing incidence of vitamin D deficiency in young 
people.20 This report and many European case series of 
children with vitamin D deficiency over the last 20 years 
have consisted primarily of immigrant children or first gen-
eration offspring of immigrant parents with dark skin. In a 
recent report from Denmark, however, half of very young 
patients with nutritional rickets were ethnic Europeans.21 
Sunscreen with a sun protection factor 15 or more blocks 
more than 99% of dermal vitamin D synthesis. Strict adher-
ence to use of sunscreens when outdoors, or the use of a 
veil, headscarf, or other concealing clothing, places indi-
viduals with fair skin at similar risk of vitamin D deficiency 
to those with pigmented skin. Elderly and institutional-
ised individuals are at risk because of the relatively large 
amount of time such people spend indoors, as well as a 
reduced dermal capacity to generate vitamin D.
Numerous case series and some experimental studies 
highlight the fact that vitamin D deficiency may be present 
at birth, with neonatal and infant vitamin D status depend-
ent upon maternal vitamin D status.w5 w6 Multiparity, short 
spacing between pregnancies, and non-white maternal 
skin are major risk factors for vitamin D deficiency.w7 22 
Infants exclusively breast fed, particularly beyond six 
months of age, are at increased risk because the vitamin D 
content of breast milk will not meet their requirements.22 
Delayed introduction of solid food, picky eating habits, and 
poor diet also raise the risk. 
The Department of Health recommends daily supple-
mentary vitamin drops containing 400 IU of calciferol 
for all infants and preschool children,23 and this view is 
endorsed by the European Society for Paediatric Endo-
crinology.24 Supplementation is particularly important 
for infants in the north of the UK, those with darker skin 
pigmentation, and fussy eaters.23 
Weaning foods frequently contain low quantities of cal-
cium, and nutritional rickets (as a consequence of calcium 
and not vitamin D deficiency) has been reported in children 
with adequate levels of 25-OHD.w8 Such findings reinforce 
the importance of focusing on the calcium content of a 
child’s diet in addition to vitamin D status.w9
how do patients with vitamin D deficiency present?
Children
Severe vitamin D deficiency may cause hypocalcaemic 
seizures or tetany, particularly in the neonatal period and 
again during the phase of rapid growth in adolescence. 
From the age of 6 months, children with vitamin D defi-
ciency commonly present with bony deformity (rickets). 
Bowing of the legs (genu varum) is typical, but knock knees 
(genu valgum) can also occur. Anterior bowing of the femur 
and internal rotation at the ankle are frequently found, 
along with swelling at the wrist, prominent costochon-
dral joints, and a soft, deformable skull (craniotabes).25 
Children with vitamin D deficiency may be irritable and 
reluctant to weight bear, and manifest impaired growth.21 22 
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unanSwereD queStionS
How much does vitamin D insufficiency contribute to •	
north/south health inequality in the UK?
Would eradication of vitamin D insufficiency in the UK •	
reduce cancer incidence and improve cancer outcomes?
Does poor vitamin D status cause obesity, or is it a •	
consequence of obesity?
Are individuals genetically susceptible to vitamin D •	
insufficiency or toxicity?
ongoing reSearCH 
More than 150 clinical trials of vitamin D are listed on 
ClinicalTrials.gov. Some key trials include:
The VITamin D and omegA-3 TriaL (VITAL)•	
A study of colecalciferol 2000 IU daily, fish oil, or placebo •	
in 20 000 older individuals (>60 yrs), with cardiovascular 
disease and cancer incidence as outcomes.
Vitamin D and Calcium Homeostasis for Prevention of •	
Type 2 Diabetes (CaDDM) (NCT00436475)
Treatment of vitamin D insufficiency: does vitamin D •	
increase calcium absorption, bone mass and muscle 
mass and function in women past menopause who have 
mildly low vitamin D levels? (NCT00933244)
Evaluation of vitamin D requirements during pregnancy •	
(NCT00292591)
Development of vitamin D as a therapy for breast •	
cancer—phase II (NCT00656019)
Vitamin D supplement in preventing colon cancer in •	
African Americans with colon polyps (NCT00870961)
Health benefits of vitamin D and calcium in women with •	
PCOS (polycystic ovarian syndrome) (NCT00743574)
Vitamin D•	 3 supplementation and the T cell compartment 
in multiple sclerosis (MS) (NCT00940719)
Height is usually affected more profoundly than weight.21 
An increased susceptibility to infections and respira-
tory symptoms in children with vitamin D deficiency may 
be a manifestation of “rachitic lung,” where respiratory 
function is compromised by a pliable rib cage and muscle 
weakness.w10 Severe vitamin D deficiency can result in car-
diomyopathy and potentially fatal heart failure.w11
adults
Pain and proximal muscle weakness dominate the clinical 
picture of vitamin D deficiency in adults. Rib, hip, pelvis, 
thigh, and foot pain are typical. More diffuse muscular aches 
and muscle weakness, including in the limbs and back, are 
also common and may be labelled as “fibromyalgia” or as 
a somatisation of depression.26 Low bone density on dual 
energy x ray absorptiometry scanning, or osteopenia on 
plain radiography, may also reflect osteomalacia, and these 
findings warrant assessment of vitamin D status.
what investigations are necessary?
Children
Vitamin D deficiency should be suspected in children with 
known risk factors who are unwell with pain, irritability, 
and poor growth or skeletal deformity, and in all children 
with a seizure disorder. Blood can be taken in primary care 
for measurement of levels of calcium, phosphate, alkaline 
phosphatase, and serum 25-OHD, which is the most robust 
marker for vitamin D status (table 1). Haemoglobin levels 
should also be measured because iron deficiency anaemia 
frequently coexists with rickets.w12 Parathyroid hormone 
concentrations are typically elevated in neonates and 
young infants with vitamin D deficiency, but may be within 
the reference range. 
If there is diagnostic uncertainty—because of atypical 
clinical manifestations, a lack of risk factors, atypical bio-
chemistry, focal pain, or asymmetrical deformity—then 
radiographs should be arranged to confirm rickets. In addi-
tion, a small number of children have hereditary or renal 
rickets. These rarer diagnoses need to be considered in the 
absence of known risk factors, in the presence of atypical 
biochemistry (for example, persistent hypophosphat aemia, 
normal alkaline phosphatase, or elevated creatinine), 
and in children who fail to reduce alkaline phosphatase 
 levels or respond clinically following vitamin D treatment. 
 Referral for specialist assessment is appropriate in these 
circumstances.
The clinician must be vigilant for a secondary cause of vita-
min D deficiency in both children and adults, such as covert 
coeliac disease or cystic fibrosis causing  malabsorption.
adults
More than 80% of adults with osteomalacia have a high con-
centration of serum alkaline phosphatase. Hypocal caemia 
and hypophosphataemia are less consistently present, 
depending on the severity and chronicity of the disease and 
the patient’s dietary calcium intake. Elevation of plasma 
pa rathyroid hormone—secondary hyperparathyroidism—is 
typical of osteomalacia but is not found in about 20% of 
adults with vitamin D insufficiency. It is good practice to 
image areas of focal pain in adults, particularly if they persist 
or worsen during treatment (suggesting bony metastases).27
how should rickets and osteomalacia be treated?
Children
Oral calciferol in the bioequivalent forms of either ergocal-
ciferol (yeast derived vitamin D2) or colecalciferol (fish or 
lanolin derived vitamin D3) is the treatment of choice for 
children with rickets.9 25 27 The principal aim of therapy is 
to replenish vitamin D stores; patients are then continued 
on a lower maintenance dose. Large bolus doses are also 
equally effective. Tablet, capsule, or oily suspensions of 
calciferol are available (box 3). 
Children aged less than 1 year should be treated with 
3000 IU of calciferol daily, increasing to 6000 IU daily 
after 1 year of age (box 4).22 24 Calcium supplementation 
(50 mg/kg a day) is advisable during the first weeks of ther-
apy in the growing child.22 20 A maintenance dose of 400 
IU calciferol daily is appropriate for a child of any age.22 A 
relatively rapid biochemical response is typically seen in 
children, with normalisation of alkaline phosphatase levels 
within three months. It is likely that the mother, siblings, 
and other family members of a child with rickets are also 
vitamin D deficient.9 At a minimum, a maintenance dose of 
calciferol is recommended for other family members.
adults
Calciferol has a high therapeutic index. It has been esti-
mated that a regular daily dose of 1000 IU raises serum 
25-OHD by 25 nmol/l28; however, vitamin D toxicity occurs 
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tiPS For tHe non-SPeCialiSt
Suspicions regarding a suboptimal vitamin D status in •	
someone at risk are likely to be correct
Treatment is not the same as supplementation: the •	
recommended daily amount of 400 IU vitamin D will be 
insufficient to treat an adult with osteomalacia and will 
lead to very slow response in most children with rickets
If a child has vitamin D insufficiency or deficiency, •	
assume the mother and other siblings are similarly 
affected and will need therapy as well
Compliance with long term vitamin D supplementation •	
is often poor: one off, high dose oral or intramuscular 
therapy is an effective option if concordance is suspect
aDDitional eDuCational reSourCeS
resources for healthcare professionals
Diseases of Bone and Mineral Metabolism (www.endotext.
org/parathyroid/index.htm)—online textbook 
Scientific advisory committee on nutrition update on 
vitamin D (www.sacn.gov.uk/pdfs/sacn_07_04.pdf)
at 25-OHD values above 500 nmol/l.29 In adults, calciferol 
treatment, in a daily dose of 10 000 IU or a weekly dose of 
60 000 IU, will lead to restoration of body stores of vita-
min D over eight to 12 weeks. Thereafter, a maintenance 
dose of 1000-2000 IU calciferol daily or 10 000 IU weekly 
is adequate. Short acting, potent vitamin D analogues such 
as 1-α calcidol or calcitriol are ineffective in correcting vita-
min D deficiency and may lead to hypercalcaemia. Clini-
cians should avoid giving combined calcium and vitamin 
D preparations in the long term because the calcium com-
ponent is usually unnecessary, makes for unpalatability, 
and reduces concordance.
In adults with severe malabsorption, or those in whom 
concordance with oral therapy is suspect, an intramuscu-
lar dose of 300 000 IU calciferol monthly for three months 
followed by the same dose once or twice a year is an alter-
native treatment approach. Pathological lesions in the 
bone are characterised by undermineralisation and may 
take many months to heal. Levels of serum alkaline phos-
phatase and parathyroid hormone will start to decline dur-
ing the first three months of treatment in adults, but may 
take a year to fall into the reference range. Given that few 
adults have truly reversible risk factors for vitamin D defi-
ciency, the assumption should be that supplementation 
will be needed life long, or life long during winter months 
(dependent upon latitude and dress habits).
how should moderate vitamin D insufficiency be 
managed?
From a public health perspective, primary prevention of 
vitamin D deficiency in a country such as the UK is socially 
as well as medically justifiable.30 The key groups for health-
care professionals to target are infants, children, adoles-
cents, and pregnant women, particularly those with dark 
skin. Many individuals of non-white ancestry living in the 
Midlands and north of the UK are at particularly high risk 
of vitamin D insufficiency (including doctors). Most eld-
erly and institutionalised people in other areas of the UK 
are also at high risk. Fair skinned people who eat oily fish 
twice weekly or who get regular suberythematous sunlight 
exposure through outdoor work or leisure activity may have 
adequate vitamin D status; most other fair skinned people 
will be vitamin D insufficient, particularly in the winter 
and spring. 
Given the clear and mounting evidence of the substan-
tial disease burden associated with moderate vitamin D 
ins ufficiency (table 2), information about appropriate 
sunlight exposure, the use of vitamin D supplements, 
and eating oily fish should be made available to the whole 
population. In particular, health visitors and midwives can 
implement current Department of Health recommendations 
by distributing children’s vitamin drops, which should be 
universally available through Healthy Start, Sure Start, and 
similar government schemes. Furthermore, we believe that 
a more robust approach to statutory food supplementation 
with vitamin D (for example, in milk) is needed in the UK, 
as this measure has already been introduced successfully 
in many other countries at similar latitude.
Conclusions
Vitamin D deficiency and insufficiency are common in the 
UK. Health professionals have been slow to respond to this 
problem even though the issue has been highlighted in the 
literature for a number of years. Rickets and osteomala-
cia are entirely preventable diseases that are becoming 
increasingly common in the UK population, and vitamin 
D insufficiency now seems unequivocally linked to several 
other common and morbid conditions. Local initiatives 
have been implemented to address this issue, but the high 
number of patients presenting with symptomatic vitamin 
D insufficiency highlights the fact that we have some way to 
go. A change in UK public health policy is long overdue.
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STATISTICAL 
qUESTIoN
Sampling iii
c
1  The Apgar score consists of the following items, each of which can be scored 0, 1, or 2 points: 
heart rate; respiratory effort; muscle tone; reflex irritability; and colour.
2  Oesophageal atresia can be seen on the chest radiograph (figure). The radio-opaque nasogastric 
tube is curled up in a blind, dilated upper oesophageal pouch.
3  A double lumen catheter (“Replogle suction catheter”) should be placed in the upper 
oesophageal pouch to suction secretions and prevent their aspiration. Administration of 
parenteral nutrition and fluid replacement should be initiated. Surgical repair of the oesophageal 
atresia and ligation of any associated tracheo-oesophageal fistula is indicated.
4  The majority of associated anomalies involve one or more of the components that constitute 
VACTERL association: vertebral anomalies, anorectal atresia or stenosis, cardiovascular defects, 
tracheo-oesophageal atresia, renal defects, and limb abnormalities.
5  The umbilical catheter was, unintentionally, positioned in an umbilical artery, which is not the 
preferred route for administration of parenteral nutrition.
annotated chest and abdominal radiograph. (a) nasogastric tube curled up in a blind, dilated upper 
oesophageal pouch. (B) Fingers of the nurse holding the patient. (C) Cardiorespiratory monitoring electrodes. 
(D) Holes in the incubator roof. (e) air in the digestive tract. (F) arterial umbilical catheter
PICTURE qUIZ a congenital anomaly in a preterm newborn
1  The suspected diagnosis is acute pancreatitis secondary to hypertriglyceridaemia.
2  Hypertriglyceridaemia interferes with the serum amylase assay and can produce a falsely low result—serum 
amylase can seem to be within normal limits despite clinical and radiological evidence of acute pancreatitis.
3  Urine amylase to creatinine ratio can be measured to diagnose acute pancreatitis, and the result of this test is 
less likely to be affected by hypertriglyceridaemia. Alternatives are the removal of lipids before serum amylase 
measurement by using ultracentrifugation.
4  This patient has ongoing severe epigastric pain and a computed tomography scan of the abdomen (considered 
the “gold standard” test in the diagnosis of acute pancreatitis) should be organised.
CASE REPoRT Diagnostic difficulties with a lipaemic blood sample
